Dry Needling for Shoulder Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Texas Woman's University, Dallas, TX
Shoulder Pain+1 More
Dry Needling - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Shoulder pain is one of the most common reasons people consult with their primary health care provider, and 40-50% of these patients with shoulder pain continued to complain of persistent symptoms after 6 to 12 months. It has been suggested that the presence of myofascial trigger points (MTrPs) may contribute to the chronicity of shoulder symptoms. An MTrP is a hyperirritable taut band of tissue within a muscle that produces pain when stimulated MTrPs are common in patients with shoulder disorders and occur most often in the infraspinatus muscle of a painful shoulder MTrPs were associated with an acidic biochemical environment with elevated levels of inflammatory mediators, neuropeptides, and proinflammatory cytokines such as bradykinin and calcitonin g-related peptide. It was hypothesized that metabolic demands on muscle and capillary constrictions may contribute to the development of MTrPs. To date, only a few studies have examined the vascular environment of MTrPs and surrounding areas before and after dry needling. No studies have yet examined whether dry needling would change blood flow in patients with shoulder pathology. Therefore, the purpose of this pilot study is to examine the effect of dry needling on blood flow of the infraspinatus muscle using color Doppler imaging in individuals with and without shoulder pain.

Eligible Conditions

  • Shoulder Pain
  • Dry Needling

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 2 Secondary · Reporting Duration: Change from baseline EDV immediately

Change from baseline EDV immediately
End Diastolic Velocity (EDV)
Change from baseline PI immediately
Pulsatile Index (PI)
Change from baseline PSV immediately
Peak Systolic Velocity (PSV)
Change from baseline Pain Pressure Threshold immediately
Pain Pressure Thresholds
Change from baseline RI immediately
Resistive Index (RI)
Change from baseline shoulder range of motion immediately
Shoulder Range of Motion

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Individuals with and without Shoulder Pain
1 of 1
Experimental Treatment

60 Total Participants · 1 Treatment Group

Primary Treatment: Dry Needling · No Placebo Group · N/A

Individuals with and without Shoulder Pain
Other
Experimental Group · 1 Intervention: Dry Needling · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change from baseline edv immediately
Closest Location: Texas Woman's University · Dallas, TX
Photo of Dallas 1Photo of Dallas 2Photo of Dallas 3
2016First Recorded Clinical Trial
2 TrialsResearching Shoulder Pain
28 CompletedClinical Trials

Who is running the clinical trial?

Texas Woman's UniversityLead Sponsor
76 Previous Clinical Trials
5,287 Total Patients Enrolled
2 Trials studying Shoulder Pain
114 Patients Enrolled for Shoulder Pain
Jace A BrownPrincipal InvestigatorTexas Woman's University

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
The test is positive if there is a MTrP in the infraspinatus as determined by palpation.
You have a diagnosis of MTrP with referral pain pattern in the infraspinatus muscle determined through palpation.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References